![Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3121dc0d275c4e93aba9b2b6a72278e3d49ffd0e/1-Figure1-1.png)
Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar
![Figure 2 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar Figure 2 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3121dc0d275c4e93aba9b2b6a72278e3d49ffd0e/2-Figure2-1.png)
Figure 2 from Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. | Semantic Scholar
![Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia | CNS Drugs Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia | CNS Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40263-023-01022-7/MediaObjects/40263_2023_1022_Fig5_HTML.png)
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia | CNS Drugs
![Frontiers | The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease Frontiers | The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease](https://www.frontiersin.org/files/Articles/1039725/fpsyt-13-1039725-HTML-r1/image_m/fpsyt-13-1039725-g001.jpg)
Frontiers | The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
![The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms - ScienceDirect The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0028390816301198-fx1.jpg)
The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms - ScienceDirect
![The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole | SpringerLink The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-319-56015-1_424-1/MediaObjects/430333_0_En_424-1_Fig2_HTML.png)
The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole | SpringerLink
![Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20220518160015-29724-mediumThumb-99288fig5_3.jpg?pub-status=live)
Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology
![IJMS | Free Full-Text | Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems IJMS | Free Full-Text | Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems](https://www.mdpi.com/ijms/ijms-22-09315/article_deploy/html/images/ijms-22-09315-g001.png)
IJMS | Free Full-Text | Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems
![The effects of the dopamine stabilizer (−)-OSU6162 on aggressive and sexual behavior in rodents | Translational Psychiatry The effects of the dopamine stabilizer (−)-OSU6162 on aggressive and sexual behavior in rodents | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Ftp.2016.12/MediaObjects/41398_2016_Article_BFtp201612_Fig1_HTML.jpg)
The effects of the dopamine stabilizer (−)-OSU6162 on aggressive and sexual behavior in rodents | Translational Psychiatry
![Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20220518160015-18228-mediumThumb-99288fig5_19.jpg?pub-status=live)
Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics” (Chapter 5) - Stahl's Essential Psychopharmacology
![Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00603/article_deploy/html/images/pharmaceuticals-16-00603-g001.png)
Pharmaceuticals | Free Full-Text | Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders
![Aripiprazole , a “ Dopamine-Serotonin System Stabilizer ” in the Treatment of Psychosis | Semantic Scholar Aripiprazole , a “ Dopamine-Serotonin System Stabilizer ” in the Treatment of Psychosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b2563b48f01b39602a0aa78b807593cf6ef3da88/2-Figure1-1.png)
Aripiprazole , a “ Dopamine-Serotonin System Stabilizer ” in the Treatment of Psychosis | Semantic Scholar
![The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole | SpringerLink The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-319-56015-1_424-1/MediaObjects/430333_0_En_424-1_Fig3_HTML.png)